Expand ARDX Menu
ARDX MENU

ARDX Latest Press Releases

-- May 19, 2026 --

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 Globe Newswire 8:01 AM

-- May 7, 2026 --

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF's Spring Clinical Meetings Globe Newswire 8:01 AM

-- April 30, 2026 --

Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:01 PM

-- April 27, 2026 --

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF's Spring Clinical Meetings Globe Newswire 8:01 AM

-- April 20, 2026 --

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer Globe Newswire 8:00 AM

-- April 16, 2026 --

Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 Globe Newswire 8:01 AM

-- April 1, 2026 --

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx Globe Newswire 8:01 AM

-- March 12, 2026 --

Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award Globe Newswire 8:00 AM

-- March 9, 2026 --

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C Globe Newswire 4:05 PM

-- March 4, 2026 --

Ardelyx to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- February 24, 2026 --

Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions Globe Newswire 8:00 AM

-- February 19, 2026 --

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:01 PM

-- February 5, 2026 --

Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 Globe Newswire 8:00 AM

-- February 3, 2026 --

Ardelyx Receives New Patent for Tenapanor Globe Newswire 8:29 AM

-- January 28, 2026 --

First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA Globe Newswire 8:29 AM

-- January 23, 2026 --

Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets Globe Newswire 12:56 PM

-- January 8, 2026 --

Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes